COVID-19 and AMR – what do we know so far?

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus that was only recently discovered in 2019. The virus causes the COVID-19 pandemic which currently requires the full focus, commitment and support from all governments, international institutions and organizations, the healthcare workforce, the private sector, civil society and the general public.

Some attention has started to be given to the role of secondary infections as well as antibiotic resistance in patients with COVID-19. Currently, however, too little information is available to draw any full conclusions on the potential impact antibiotic resistance might have on COVID-19 outcomes.